Adrian Towse has no conflicts to declare.
Net Clinical Benefit: The Art and Science of Jointly Estimating Benefits and Risks of Medical Treatment
Version of Record online: 1 JUL 2010
© 2010, International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Value in Health
Special Issue: Apples & Oranges? Assessing Comparative Effectiveness and Comparative Value in the US and Other Countries
Volume 13, Issue Supplement s1, pages S30–S32, June/July 2010
How to Cite
Towse, A. (2010), Net Clinical Benefit: The Art and Science of Jointly Estimating Benefits and Risks of Medical Treatment. Value in Health, 13: S30–S32. doi: 10.1111/j.1524-4733.2010.00753.x
- Issue online: 1 JUL 2010
- Version of Record online: 1 JUL 2010
- 1Balancing benefits and harms in health care. BMJ 2004;329:30..
- 2Challenges and opportunities for improving benefit-risk assessment of pharmaceuticals from an economic perspective. Office of Health Economics 2008. Available from: http://www.ohe.org/page/publications/publication.cfm?catid=28&archive=0&itemid=615[Accessed May 27, 2010., .
- 3Benefit-Risk Appraisal of Medicines. Oxford: Wiley-Blackwell, 2009., , .
- 7Using incremental net benefit for quantitative benefit-risk analysis case studies of Vioxx® and Lotronex®. Presented at the Benefit-Risk Assessments for Drugs Workshop. Office of Health Economics. October 24, 2007..
- 10Deliberative processes. Office of Health Economics 2009..